Drug Information for EPOPROSTENOL (GeneraMedix Inc ): INDICATIONS AND USAGE

  • Epoprostenol is indicated for:

    • the long-term intravenous treatment of primary pulmonary hypertension
    • and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy
    • [see CLINICAL STUDIES: Clinical Trials in Pulmonary Hypertension (14.1) ].
  • Drug Information Provided by National Library of Medicine (NLM).